151 related articles for article (PubMed ID: 32930113)
1. The effect of kanglaite injection in combination with gefitinib versus gefitinib alone in patients with nonsmall cell lung cancer: A meta-analysis.
Hailang H; Jiping Z; Ailing C; Xianmei Z
J Cancer Res Ther; 2020; 16(4):745-751. PubMed ID: 32930113
[TBL] [Abstract][Full Text] [Related]
2. Kanglaite injection plus platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 27 RCTs.
Huang X; Wang J; Lin W; Zhang N; Du J; Long Z; Yang Y; Zheng B; Zhong F; Wu Q; Ma W
Phytomedicine; 2020 Feb; 67():153154. PubMed ID: 31926475
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Kanglaite plus EGFR-TKI in the treatment of advanced non-small cell lung cancer: A meta-analysis of 13 RCTs.
Li D; Li W; Xu L; Che Y; Cheng C
Medicine (Baltimore); 2022 Dec; 101(50):e32169. PubMed ID: 36550917
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Kanglaite injection combined with first-line platinum-based chemotherapy in patients with advanced NSCLC: a systematic review and meta-analysis of 32 RCTs.
Li J; Li HZ; Zhu GH; Gao RK; Zhang Y; Hou W; Li J
Ann Palliat Med; 2020 Jul; 9(4):1518-1535. PubMed ID: 32692199
[TBL] [Abstract][Full Text] [Related]
5. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
6. Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines.
Wang J; Li G; Yu L; Mo T; Wu Q; Zhou Z
J Ethnopharmacol; 2018 Jul; 221():137-150. PubMed ID: 29655852
[TBL] [Abstract][Full Text] [Related]
7. Kanglaite injection combined with chemotherapy versus chemotherapy alone in the treatment of advanced non-small cell lung carcinoma.
Liu X; Yang Q; Xi Y; Yu K; Wang W; Zhao X; Kou X
J Cancer Res Ther; 2014 Aug; 10 Suppl 1():46-51. PubMed ID: 25207891
[TBL] [Abstract][Full Text] [Related]
8. Evidence of Astragalus injection combined platinum-based chemotherapy in advanced nonsmall cell lung cancer patients: A systematic review and meta-analysis.
Cao A; He H; Wang Q; Li L; An Y; Zhou X
Medicine (Baltimore); 2019 Mar; 98(11):e14798. PubMed ID: 30882655
[TBL] [Abstract][Full Text] [Related]
9. Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III/IV non-small cell lung cancer: A meta-analysis following the PRISMA guidelines.
Wang X; Liu Z; Sui X; Wu Q; Wang J; Xu C
Phytomedicine; 2019 Jun; 59():152787. PubMed ID: 31005810
[TBL] [Abstract][Full Text] [Related]
10. Kanglaite injection plus chemotherapy versus chemotherapy alone for non-small cell lung cancer patients: A systematic review and meta-analysis.
Liu X; Xu F; Wang G; Diao X; Li Y
Curr Ther Res Clin Exp; 2008 Oct; 69(5):381-411. PubMed ID: 24692815
[TBL] [Abstract][Full Text] [Related]
11. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
[TBL] [Abstract][Full Text] [Related]
12. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
Liu ZL; Zhu WR; Zhou WC; Ying HF; Zheng L; Guo YB; Chen JX; Shen XH
J Integr Med; 2014 Jul; 12(4):346-58. PubMed ID: 25074884
[TBL] [Abstract][Full Text] [Related]
13. Injectable Chinese herbal formula Kang'ai for nonsmall cell lung cancer: Trial sequential analysis of 2,259 participants from 31 randomized controlled trials.
He XR; Han SY; Li PP
J Cancer Res Ther; 2016; 12(2):735-43. PubMed ID: 27461643
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of NSCLC ancillary treatment with compound Kushen injection through immunocompetence regulation: A systematic review and meta-analysis.
Wang D; Xu Y; Huang T; Peng W; Zhu D; Zhou X; Wu Q
Phytomedicine; 2022 Sep; 104():154315. PubMed ID: 35868145
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the therapeutic effect of gefitinib combined with chemotherapy and chemotherapy alone in treating non-small cell lung cancer.
Zhao Q; Sun K; Lei X; Cai L
Medicine (Baltimore); 2020 Jul; 99(31):e21490. PubMed ID: 32756179
[TBL] [Abstract][Full Text] [Related]
16. Gefitinib with or without Transarterial Infusion Chemotherapy (Cisplatin) for Large Nonsmall Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations.
Zhang YQ; Jiang LJ; Jiang SX; Xu YF; Zhou BB; Huang GH; Liu DM; Wang Y; Fan WZ; Li JP; Wang B
J Vasc Interv Radiol; 2019 Jul; 30(7):1004-1012. PubMed ID: 31171399
[TBL] [Abstract][Full Text] [Related]
17. Kanglaite injection plus fluorouracil-based chemotherapy on the reduction of adverse effects and improvement of clinical effectiveness in patients with advanced malignant tumors of the digestive tract: A meta-analysis of 20 RCTs following the PRISMA guidelines.
Song Q; Zhang J; Wu Q; Li G; Leung EL
Medicine (Baltimore); 2020 Apr; 99(17):e19480. PubMed ID: 32332600
[TBL] [Abstract][Full Text] [Related]
18. Xiao-ai-ping injection adjunct with platinum-based chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Feng F; Huang J; Wang Z; Zhang J; Han D; Wu Q; He H; Zhou X
BMC Complement Med Ther; 2020 Jan; 20(1):3. PubMed ID: 32020869
[TBL] [Abstract][Full Text] [Related]
19. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
Yang XB; Wu WY; Long SQ; Deng H; Pan ZQ; He WF; Zhou YS; Liao GY; Li QP; Xiao SJ; Cai JZ
Trials; 2015 Apr; 16():146. PubMed ID: 25873045
[TBL] [Abstract][Full Text] [Related]
20. Chinese Herbal Medicine for Improving Quality of Life Among Nonsmall Cell Lung Cancer Patients: Overview of Systematic Reviews and Network Meta-Analysis.
Wu X; Chung VCH; Lu P; Poon SK; Hui EP; Lau AYL; Balneaves LG; Wong SYS; Wu JCY
Medicine (Baltimore); 2016 Jan; 95(1):e2410. PubMed ID: 26735544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
